Expression of human telomerase catalytic protein in gallbladder carcinogenesis

Journal of Clinical Pathology

Volumn 58, Issue 8, 2005, Pages 820-825

  Luzar, B ^a   Poljak, M ^a   Cor A ^a   Klopcic U ^b   Ferlan Marolt, V ^a  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

^b INSTITUTE OF ONCOLOGY   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

TELOMERASE REVERSE TRANSCRIPTASE;

ADENOCARCINOMA; ARTICLE; CANCER GRADING; CARCINOGENESIS; CATALYST; CONTROLLED STUDY; DYSPLASIA; GALLBLADDER CARCINOMA; GALLBLADDER EPITHELIUM; HUMAN; HUMAN TISSUE; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGENERATION;

ADENOCARCINOMA; CELL TRANSFORMATION, NEOPLASTIC; DISEASE PROGRESSION; DNA-BINDING PROTEINS; GALLBLADDER NEOPLASMS; HUMANS; IMMUNOENZYME TECHNIQUES; NEOPLASM PROTEINS; PRECANCEROUS CONDITIONS; RETROSPECTIVE STUDIES; TELOMERASE;

EID: 23444459349     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.2004.023143     Document Type: Article

References (42)

1. Itoi T, Watanabe H, Ajioka Y, et al. APC, K-ras codon 12 mutations and p53 gene expression in carcinoma and adenoma of the gall-bladder suggest two genetic pathways in gall-bladder carcinogenesis. Pathol Int 1996;46:333-40.
2. Chang HJ, Kim SW, Kim YT, et al. Loss of heterozygosity in dysplasia and carcinoma of the gallbladder. Mod Pathol 1999;12:763-9.
3. Wistuba II, Sugio K, Hung J, et al. Allele-specific mutations involved in the pathogenesis of endemic gallbladder carcinoma in Chile. Cancer Res 1995;55:2511-15.
4. Wistuba II, Miquel JF, Gazdar AF, et al. Gallbladder adenomas have molecular abnormalities different from those present in gallbladder carcinomas. Hum Pathol 1999;30:21-5.
5. Sasatomi E, Tokunaga O, Miyazaki K. Precancerous conditions of gallbladder carcinoma: overview of histopathologic characteristics and molecular genetic findings. J Hepatobiliary Pancreat Surg 2000;7:556-67.
6. Hui AM, Li X, Shi YZ, et al. Cyclin D1 overexpression is a critical event in gallbladder carcinogenesis and independently predicts decreased survival for patients with gallbladder carcinoma. Clin Cancer Res 2000;6:4272-7.
7. Hui AM, Li X, Shi YZ, et al. p27(Kip1) expression in normal epithelia, precancerous lesions, and carcinomas of the gallbladder: association with cancer progression and prognosis. Hepatology 2000;31:1068-72.
8. Blackburn EH. Structure and function of telomeres. Nature 1991;350:569-73.
9. Griffith JD, Comeau L, Rosenfield S, et al. Mammalian telomeres end in a large duplex loop. Cell 1999;97:503-14.
10. Olovnikov AM. A theory of marginotomy. The incomplete copying of template margin in enzymatic synthesis of polynucleotides and biological significance of the phenomenon. J Theor Biol 1973;41:181-90.
11. Blackburn EH. Switching and signaling at the telomere. Cell 2001;106:601-73.
12. Meyerson M, Counter CM, Eaton EN, et al. hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell 1997;90:785-95.
13. Feng J, Funk WD, Wang SS, et al. The RNA component of human telomerase. Science 1995;269:1236-41.
14. Nakamura TM, Morin GB, Chapman KB, et al. Telomerase catalytic subunit homologs from fission yeast and human. Science 1997;277:955-9.
15. Saito T, Matsuda Y, Suzuki T, et al. Comparative gene mapping of the human and mouse TEP1 genes, which encode one protein component of telomerases. Genomics 1997;46:46-50.
16. Counter CM, Meyerson M, Eaton EN, et al. Telomerase activity is restored in human cells by ectopic expression of hTERT (hEST2), the catalytic subunit of telomerase. Oncogene 1998;16:1217-22.
17. Koyanagi Y, Kobayashi D, Yajima T, et al. Telomerase activity is down regulated via decreases in hTERT mRNA but not TEP1 mRNA or hTERC during the differentiation of leukemic cells. Anticancer Res 2000;20:773-8.
18. Kilian A, Bowtell DD, Abud HE, et al. Isolation of a candidate human telomerase catalytic subunit gene, which reveals complex splicing patterns in different cell types. Hum Mol Genet 1997;6:2011-19.
19. Ulaner GA, Hu JF, Vu TH, et al. Tissue-specific alternate splicing of human telomerase reverse transcriptase (hTERT) influences telomere lengths during human development. Int J Cancer 2001;91:644-9.
20. Kotoula V, Hytirogllou P, Pyrpasopoulou A, et al. Expression of human reverse transcriptase in regenerative and precancerous lesions of cirrhotic nodules. Liver 2002;22:57-69.
21. Wright WE, Piatyszek MA, Rainey WE, et al. Telomerase activity in human germline and embryonic tissues and cells. Dev Genet 1996;18:173-9.
22. Harley CB, Futcher AB, Greider CW. Telomeres shorten during ageing of human fibroblast. Nature 1990;345:458-60.
23. Dhaene K, Van Marck E, Parwaresch R. Telomeres, telomerase and cancer: an up-date. Virchows Arch 2000;437:1-16.
24. Holt SE, Shay JW. Role of telomerase in cellular proliferation and cancer. J Cell Physiol 1999;180:10-18.
25. Frierson HF Jr. Gallbladder and extrahepatic biliary system. In: Sternberg SS, ed. Histology for pathologists. New York: Lippincott Raven, 1997:593-612.
26. Albores-Saavedra J, Henson DE, Sobin LH. Definitions and explanatory notes. In: WHO histological typing of tumors of the gallbladder extrahepatic bile ducts. Berlin: Springer Verlag, 1991:7-21.
27. Niiyama H, Mizumoto K, Kusumoto M, et al. Activation of telomerase and its diagnostic application in biopsy specimens from biliary tract neoplasms. Cancer 1999;85:2138-43.
28. Itoi T, Shinohara Y, Takeda K, et al. Detection of telomerase activity in biopsy specimens for diagnosis of biliary tract cancers. Gastrointest Endosc 2000;52:380-6.
29. De Kolk JB, Rues TJ, van Muijen GN, et al. Real-time quantification of human telomerase reverse transcriptase mRNA in tumors and healthy tissues. Clin Chem 2000;46:313-18.
30. De Kolk JB, Schalken JA, Aalders TW, et al. Quantitative measurement of telomerase reverse trascriptase (hTERT) mRNA in urothelial cell carcinomas. Int J Cancer 2000;87:217-20.
31. Kyo S, Kanaya T, Takakura M, et al. Human telomerase reverse transcriptase as a critical determinant of telomerase activity in normal and malignant endometrial tissues. Int J Cancer 1999;80:60-3.
32. Itoi T, Shinohara Y, Takeda K, et al. Detection of telomerase reverse transcriptase mRNA in biopsy specimens and bile for the diagnosis of biliary tract cancers. Int J Mol Med 2001;7:281-7.
33. Uchida N, Tsutsui K, Ezaki T, et al. A case of gallbladder carcinoma diagnosed preoperatively by the detection of human telomerase reverse transcriptase mRNA in endoscopically obtained gallbladder bile. Endoscopy 2003;35:185-8.
34. Van P, Benhattar J, Seelentag W, et al. Immunohistochemical localization of hTERT protein in human tissues. Histochem Cell Biol 2004;121:391-7.
35. Wong JMY, Kusdra L, Collins K. Subnuclear shuttling of human telomerase induced by transformation and DNA damage. Nat Cell Biol 2002;4:731-6.
36. Kyo S, Masutomi K, Maida Y, et al. Significance of immunological detection of human telomerase reverse transcriptase: re-evaluation of expression and localization of human telomerase reverse transcriptase. Am J Pathol 2003;163:859-67.
37. Kyo S, Inoue M. Complex regulatory mechanisms of telomerase activity in normal and cancer cells: how can we apply them for cancer therapy? Oncogene 2002;21:688-97.
38. Roa I, Araya JC, Villaseca M, et al. Preneoplastic lesions and gallbladder cancer: an estimate of the period required for progression. Gastroenterology 1996;111:232-6.
39. Poole JC, Andrews LG, Tollefsbol TO. Activity, function and gene regulation of the catalytic subunit of telomerase (hTERT). Gene 2001;269:1-12.
40. Bodnar AG, Ouellette M, Frolkis M, et al. Extension of life-span by introduction of telomerase into normal human cells. Science 1998;279:349-52.
41. Lauwers GY, Riddell RH. Gastric epithelial dysplasia. Gut 1999;45:784-90.
42. Kleinsasser O. Über den Krankheitsverlauf bei Epithelhyperplasien der Kehlkopf-schleimhaut und die Entstehung von Carcinomen. Z Laryngol Rhinol Otol 1963;42:541-58.